Market Place
Sourcing Support
Hansoh’s Generics Dapagliflozin Receives Tentative Approval in US
23 Dec 2025 //
FDA
Novo Nordisk’s Wegovy Receives Approval in US
22 Dec 2025 //
FDA
RB Hlth’s Mucinex Receives Approval in US
22 Dec 2025 //
FDA
Amneal Pharms’ Biologics Oziltus Receives Approval in US
19 Dec 2025 //
FDA
Amneal Pharms’ Biologics Boncresa Receives Approval in US
19 Dec 2025 //
FDA
Boehringer Ingelheim Pharma’s Jascayd Receives Approval in US
19 Dec 2025 //
FDA
Cytokinetics’ Myqorzo Receives Approval in US
19 Dec 2025 //
FDA
Formyn AG’s Biologics Nufymco Receives Approval in US
18 Dec 2025 //
FDA
Creekwood Pharms’ Generics Haloperidol Receives Approval in US
18 Dec 2025 //
FDA
Teva’ Generics Dapagliflozin Receives Tentative Approval in US
18 Dec 2025 //
FDA
Micro’s Generics Tenofovir Disoproxil Receives Approval in US
18 Dec 2025 //
FDA
Janssen’s Biologics Rybrevant Faspro Receives Approval in US
17 Dec 2025 //
FDA
Mankind Pharma’s Generics Latanoprost Receives Approval in US
17 Dec 2025 //
FDA
Shuangcheng’s Generics Bortezomib Receives Approval in US
17 Dec 2025 //
FDA
Alembic’s Generics Travoprost Receives Approval in US
17 Dec 2025 //
FDA
Glaxosmithkline’s Biologics Exdensur Receives Approval in US
16 Dec 2025 //
FDA
Novitium’s Generics Hydroxyzine HCl Receives Approval in US
16 Dec 2025 //
FDA
Amneal Ireland’s Generics Beclomethasone Receives Approval in US
16 Dec 2025 //
FDA
Aurobindo Pharma’s Generics Cariprazine Receives Approval in US
16 Dec 2025 //
FDA
Ibsa Inst Bio’s Vybrique Receives Approval in US
16 Dec 2025 //
FDA
Ascent’ Generics Buprenorphine & Naloxone Receives Approval in US
15 Dec 2025 //
FDA
Lib ,’s Biologics Lerochol Receives Approval in US
12 Dec 2025 //
FDA
Entasis Therap’s Nuzolvence Receives Approval in US
12 Dec 2025 //
FDA
Milestone Pharma ,’s Cardamyst Receives Approval in US
12 Dec 2025 //
FDA
Amneal’s Generics Deflazacort Receives Approval in US
12 Dec 2025 //
FDA
Mylan’s Generics Octreotide Acetate Receives Approval in US
12 Dec 2025 //
FDA
Amphastar Pharms’ Generics Teriparatide Receives Approval in US
12 Dec 2025 //
FDA
LNK’s Generics Acetaminophen & Ibuprofen Receives Approval in US
11 Dec 2025 //
FDA
MSN’s Generics Norepinephrine Bitartrate Receives Approval in US
11 Dec 2025 //
FDA
Senores Pharms’ Generics Deferiprone Receives Approval in US
11 Dec 2025 //
FDA
Acadia Pharms’ Daybue Stix Receives Approval in US
11 Dec 2025 //
FDA
Biocryst Pharma,’s Orladeyo Receives Approval in US
11 Dec 2025 //
FDA
Micro’s Generics Lopinavir And Ritonavir Receives Approval in US
11 Dec 2025 //
FDA
Novitium Pharma’s Generics Omeprazole Receives Approval in US
10 Dec 2025 //
FDA
Specgx’s Generics Buprenorphine HCl Receives Approval in US
10 Dec 2025 //
FDA
Alembic’s Generics Loteprednol Etabonate Receives Approval in US
10 Dec 2025 //
FDA
Sunshine’s Generics Mirabegron Receives Tentative Approval in US
10 Dec 2025 //
FDA
Deva As’ Generics Isoproterenol HCl Receives Approval in US
10 Dec 2025 //
FDA
Aurobindo’s Generics Dapagliflozin Receives Approval in US
10 Dec 2025 //
FDA
Macleods’s Generics Doxycycline Hyclate Receives Approval in US
09 Dec 2025 //
FDA
Teva’s Receives First Generic Approval for Estradio in US
08 Dec 2025 //
FDA
Cipla’s Generics Rifaximin Receives Tentative Approval in US
08 Dec 2025 //
FDA
Caplin’s Generics Linezolid Receives Approval in US
08 Dec 2025 //
FDA
Apotex’s Generics Linagliptin Receives Tentative Approval in US
08 Dec 2025 //
FDA
Amneal’s Generics Epinephrine Receives Approval in US
08 Dec 2025 //
FDA
Teva Pharms’ Generics Estradiol Receives Approval in US
08 Dec 2025 //
FDA
Caplin’s Generics Acetaminophen Receives Approval in US
05 Dec 2025 //
FDA
Bion’s Generics Carbidopa Receives Tentative Approval in US
04 Dec 2025 //
FDA
Hopewell’s Generics Cladribine Receives Tentative Approval in US
04 Dec 2025 //
FDA
Mylan’s Generics Macitentan Receives Approval in US
03 Dec 2025 //
FDA
Sandoz’s Receives First Generic Approval for Sitagliptin in US
02 Dec 2025 //
FDA
MSN’s Generics Brivaracetam Receives Tentative Approval in US
01 Dec 2025 //
FDA
Mankind’s Generics Sugammadex Receives Tentative Approval in US
01 Dec 2025 //
FDA
Amneal’s Generics Albuterol Sulfate Receives Approval in US
01 Dec 2025 //
FDA
Otsuka Pharm’s Biologics Voyxact Receives Approval in US
25 Nov 2025 //
FDA
Apotex’s Receives First Generic Approval for Cladribine in US
24 Nov 2025 //
FDA
Zydus’ Generics Verapamil HCl Receives Approval in US
24 Nov 2025 //
FDA
Alembic Pharms’ Generics Dapagliflozin Receives Approval in US
24 Nov 2025 //
FDA
Micro’s Generics Olmesartan Medoxomil Receives Approval in US
24 Nov 2025 //
FDA
Apotex’s Ruxolitinib Receives Approval in US
21 Nov 2025 //
FDA
